Kusajili – Clinical trials directory

Result of your search per sponsor: Jesús Feris-Iglesias, MD

Woman and Man Max 99 years
Jesús Feris-Iglesias, MD Update Il y a 4 ans

Safety and Efficacy of Topical NVC-422 Gel in Impetigo This is a randomized, double-blind study comparing 0.1% NVC-422, 0.5% NVC-422 and 1.5% NVC-422 topical gel in children with impetigo.

Country Dominican Republic
organs None
Specialty None

Closed trial

More information